Author:
Arai N.,Isaji M.,Kojima M.,Mizuta E.,Kuno S.
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference16 articles.
1. Ahlskog JE, Muenter MD, Maraganore DM, Matsumoto JY, Lieberman A, Wright KF, Wheeler K (1994) Fluctuating Parkinson's disease: treatment with the long-acting dopamine agonist cabergoline. Arch Neurol 51: 1236?1241
2. Akai T, Ozawa M, Yamaguchi M, Mizuta E, Kuno S (1995) Combination treatment of the partial D2 agonist terguride with the D1 agonist SKF 82958 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys. J Pharmacol Exp Ther 273: 309?314
3. Arai N, Isaji M, Miyata H, Fukuyama J, Mizuta E, Kuno S(1995) Differential effects of three dopamine receptor agonists in MPTP-treated monkeys. J Neural Transm [P-D Sect] 10: 55?62
4. Benedetti MS, Dostert P, Barone D, Efthymiopoulos C, Peretti G, Roncucci R (1990) In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine. Eur J Pharmacol 187: 399?408
5. Calne DB (1993) Treatment of Parkinson's disease. N Engl J Med 329: 1021?1027
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献